EPIRUS Biopharmaceuticals, Inc. Repayments of Long-Term Debt
EPIRUS Biopharmaceuticals, Inc. reported Repayments of Long-Term Debt of $8.65 million for the 0-month period ending 2014-01-31, per its 10-Q filed 2014-08-11.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2014-08-11
- EPIRUS Biopharmaceuticals, Inc. repayments of long-term debt for fiscal 2013 was $8.65M.
| Period end | Repayments of Long-term Debt 0 month | Repayments of Long-term Debt 12 month |
|---|---|---|
| 2014-01-31 | $8.65M 10-Q · filed 2014-08-11 | |
| 2013-12-31 | $8.65M 10-K · filed 2014-03-14 |